Related Experiment Video
Updated: Feb 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Development of a genetic sensor that eliminates p53 deficient cells
Jovan Mircetic1, Antje Dietrich2, Maciej Paszkowski-Rogacz1
1Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, 01307, Dresden, Germany.
Abstract:
The TP53 gene fulfills a central role in protecting cells from genetic insult. Given this crucial role it might be surprising that p53 itself is not essential for cell survival. Indeed, TP53 is the single most mutated gene across different cancer types. Thus, both a theoretical and a question of significant practical applicability arise: can cells be programmed to make TP53 an essential gene? Here we present a genetic p53 sensor, in which the loss of p53 is coupled to the rise of HSV-TK expression. We show that the sensor can distinguish both p53 knockout and cells expressing a common TP53 cancer mutation from otherwise isogenic TP53 wild-type cells. Importantly, the system is sensitive enough to specifically target TP53 loss-of-function cells with the HSV-TK pro-drug Ganciclovir both in vitro and in vivo. Our work opens new ways to programming cell intrinsic transformation protection systems that rely on endogenous components.
Insights
Scientists engineered a genetic sensor to make the TP53 gene essential for cell survival. This system targets cancer cells with mutations in the TP53 gene, offering a new therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Synthetic Biology
Background:
- The TP53 gene is critical for cellular genetic stability but is frequently mutated in cancer.
- Loss of TP53 function compromises cellular defense against genetic damage, contributing to tumorigenesis.
- Currently, TP53 is not essential for cell survival, presenting a therapeutic challenge.
Purpose of the Study:
- To engineer a system that renders TP53 essential for cell survival.
- To develop a method for specifically targeting cancer cells with TP53 loss-of-function.
- To explore novel strategies for cancer therapy by programming intrinsic cellular protection.
Main Methods:
- Development of a genetic p53 sensor linking p53 loss to HSV-TK expression.
- Utilizing the Herpes Simplex Virus-Thymidine Kinase (HSV-TK) system for drug sensitivity.
- Distinguishing between TP53 wild-type, knockout, and mutated cells using the sensor.
- In vitro and in vivo validation of the sensor's targeting capability.
Main Results:
- The genetic sensor successfully coupled the loss of p53 to increased HSV-TK expression.
- The system accurately differentiated TP53 knockout and mutated cells from wild-type cells.
- TP53 loss-of-function cells were selectively targeted with the HSV-TK prodrug Ganciclovir.
- Effective targeting was demonstrated in both in vitro and in vivo experimental models.
Conclusions:
- A novel genetic sensor enables programming TP53 as an essential gene.
- This approach allows for the specific targeting of cancer cells with TP53 mutations.
- The system offers a promising new avenue for developing targeted cancer therapies.
- This work advances the concept of cell-intrinsic transformation protection systems.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
In-vitro Mutagenesis

